Literature DB >> 35058646

The evolution of synthetic receptor systems.

Janvie Manhas1,2, Hailey I Edelstein3, Joshua N Leonard4,5,6,7,8, Leonardo Morsut9,10.   

Abstract

Receptors enable cells to detect, process and respond to information about their environments. Over the past two decades, synthetic biologists have repurposed physical parts and concepts from natural receptors to engineer synthetic receptors. These technologies implement customized sense-and-respond programs that link a cell's interaction with extracellular and intracellular cues to user-defined responses. When combined with tools for information processing, these advances enable programming of sophisticated customized functions. In recent years, the library of synthetic receptors and their capabilities has substantially evolved-a term we employ here to mean systematic improvement and expansion. Here, we survey the existing mammalian synthetic biology toolkit of protein-based receptors and signal-processing components, highlighting efforts to evolve and integrate some of the foundational synthetic receptor systems. We then propose a generalized strategy for engineering and improving receptor systems to meet defined functional objectives called a 'metric-enabled approach for synthetic receptor engineering' (MEASRE).
© 2022. Springer Nature America, Inc.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35058646      PMCID: PMC9041813          DOI: 10.1038/s41589-021-00926-z

Source DB:  PubMed          Journal:  Nat Chem Biol        ISSN: 1552-4450            Impact factor:   16.174


  87 in total

1.  Engineering Synthetic Proteins to Generate Ca2+ Signals in Mammalian Cells.

Authors:  Anam Qudrat; Kevin Truong
Journal:  ACS Synth Biol       Date:  2016-12-08       Impact factor: 5.110

2.  Designing Motif-Engineered Receptors To Elucidate Signaling Molecules Important for Proliferation of Hematopoietic Stem Cells.

Authors:  Shuta Ishizuka; Chen-Yi Lai; Makoto Otsu; Hiromitsu Nakauchi; Teruyuki Nagamune; Masahiro Kawahara
Journal:  ACS Synth Biol       Date:  2018-06-21       Impact factor: 5.110

Review 3.  DREADDs (designer receptors exclusively activated by designer drugs): chemogenetic tools with therapeutic utility.

Authors:  Daniel J Urban; Bryan L Roth
Journal:  Annu Rev Pharmacol Toxicol       Date:  2014-09-25       Impact factor: 13.820

Review 4.  Mammalian gene circuits with biomolecule-responsive RNA devices.

Authors:  Hideyuki Nakanishi; Hirohide Saito
Journal:  Curr Opin Chem Biol       Date:  2019-05-23       Impact factor: 8.822

Review 5.  Chimeric Antigen Receptor Therapy.

Authors:  Carl H June; Michel Sadelain
Journal:  N Engl J Med       Date:  2018-07-05       Impact factor: 91.245

6.  Synthetic interleukin 22 (IL-22) signaling reveals biological activity of homodimeric IL-10 receptor 2 and functional cross-talk with the IL-6 receptor gp130.

Authors:  Sofie Mossner; Marcus Kuchner; Nastaran Fazel Modares; Birgit Knebel; Hadi Al-Hasani; Doreen M Floss; Jürgen Scheller
Journal:  J Biol Chem       Date:  2020-07-01       Impact factor: 5.157

7.  Synthetic cytokine receptors transmit biological signals using artificial ligands.

Authors:  Erika Engelowski; Artur Schneider; Manuel Franke; Haifeng Xu; Ramona Clemen; Alexander Lang; Paul Baran; Christian Binsch; Birgit Knebel; Hadi Al-Hasani; Jens M Moll; Doreen M Floß; Philipp A Lang; Jürgen Scheller
Journal:  Nat Commun       Date:  2018-05-23       Impact factor: 14.919

8.  Nonimmune cells equipped with T-cell-receptor-like signaling for cancer cell ablation.

Authors:  Ryosuke Kojima; Leo Scheller; Martin Fussenegger
Journal:  Nat Chem Biol       Date:  2017-11-13       Impact factor: 15.040

9.  Molecular Design, Optimization, and Genomic Integration of Chimeric B Cell Receptors in Murine B Cells.

Authors:  Theresa Pesch; Lucia Bonati; William Kelton; Cristina Parola; Roy A Ehling; Lucia Csepregi; Daisuke Kitamura; Sai T Reddy
Journal:  Front Immunol       Date:  2019-11-14       Impact factor: 7.561

Review 10.  Engineering CAR-T Cells for Next-Generation Cancer Therapy.

Authors:  Mihe Hong; Justin D Clubb; Yvonne Y Chen
Journal:  Cancer Cell       Date:  2020-07-30       Impact factor: 31.743

View more
  1 in total

Review 1.  Biomarker-driven feedback control of synthetic biology systems for next-generation personalized medicine.

Authors:  Bozhidar-Adrian Stefanov; Martin Fussenegger
Journal:  Front Bioeng Biotechnol       Date:  2022-09-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.